-
1
-
-
84872967522
-
Cancer statistics, 2013
-
Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2013 CA Cancer J. Clin. 2013, 63, 11-30
-
(2013)
CA Cancer J. Clin.
, vol.63
, pp. 11-30
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
2
-
-
0001246577
-
Neurotensin and neurotensin receptors
-
DOI 10.1016/S0165-6147(99)01357-7, PII S0165614799013577
-
Vincent, J. P.; Mazella, J.; Kitabgi, P. Neurotensin and neurotensin receptors Trends Pharmacol. Sci. 1999, 20, 302-309 (Pubitemid 29301684)
-
(1999)
Trends in Pharmacological Sciences
, vol.20
, Issue.7
, pp. 302-309
-
-
Vincent, J.-P.1
Mazella, J.2
Kitabgi, P.3
-
3
-
-
84867840947
-
Structure of the agonist-bound neurotensin receptor
-
White, J. F.; Noinaj, N.; Shibata, Y.; Love, J.; Kloss, B.; Xu, F.; Gvozdenovic-Jeremic, J.; Shah, P.; Shiloach, J.; Tate, C. G.; Grisshammer, R. Structure of the agonist-bound neurotensin receptor Nature 2012, 490, 508-515
-
(2012)
Nature
, vol.490
, pp. 508-515
-
-
White, J.F.1
Noinaj, N.2
Shibata, Y.3
Love, J.4
Kloss, B.5
Xu, F.6
Gvozdenovic-Jeremic, J.7
Shah, P.8
Shiloach, J.9
Tate, C.G.10
Grisshammer, R.11
-
4
-
-
84874408562
-
Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy
-
Wu, Z.; Martinez-Fong, D.; Tredaniel, J.; Forgez, P. Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy Front. Endocrinol. 2012, 3, 184
-
(2012)
Front. Endocrinol.
, vol.3
, pp. 184
-
-
Wu, Z.1
Martinez-Fong, D.2
Tredaniel, J.3
Forgez, P.4
-
5
-
-
79960847184
-
The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers
-
Dupouy, S.; Mourra, N.; Doan, V. K.; Gompel, A.; Alifano, M.; Forgez, P. The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers Biochimie 2011, 93, 1369-1378
-
(2011)
Biochimie
, vol.93
, pp. 1369-1378
-
-
Dupouy, S.1
Mourra, N.2
Doan, V.K.3
Gompel, A.4
Alifano, M.5
Forgez, P.6
-
6
-
-
0031949569
-
Neurotensin receptors: A new marker for human ductal pancreatic adenocarcinoma
-
Reubi, J. C.; Waser, B.; Friess, H.; Buchler, M.; Laissue, J. Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma Gut 1998, 42, 546-550 (Pubitemid 28186573)
-
(1998)
Gut
, vol.42
, Issue.4
, pp. 546-550
-
-
Reubi, J.C.1
Waser, B.2
Friess, H.3
Buchler, M.4
Laissue, J.5
-
7
-
-
67650790442
-
Cancer, chemistry, and the cell: Molecules that interact with the neurotensin receptors
-
Myers, R. M.; Shearman, J. W.; Kitching, M. O.; Ramos-Montoya, A.; Neal, D. E.; Ley, S. V. Cancer, chemistry, and the cell: molecules that interact with the neurotensin receptors ACS Chem. Biol. 2009, 4, 503-525
-
(2009)
ACS Chem. Biol.
, vol.4
, pp. 503-525
-
-
Myers, R.M.1
Shearman, J.W.2
Kitching, M.O.3
Ramos-Montoya, A.4
Neal, D.E.5
Ley, S.V.6
-
8
-
-
57249115097
-
A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours
-
Garcia-Garayoa, E.; Blauenstein, P.; Blanc, A.; Maes, V.; Tourwé, D.; Schubiger, P. A. A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours Eur. J. Nucl. Med. Mol. Imaging 2009, 36, 37-47
-
(2009)
Eur. J. Nucl. Med. Mol. Imaging
, vol.36
, pp. 37-47
-
-
Garcia-Garayoa, E.1
Blauenstein, P.2
Blanc, A.3
Maes, V.4
Tourwé, D.5
Schubiger, P.A.6
-
9
-
-
77956138237
-
Synthesis of a Ga-68-labeled peptoid-peptide hybrid for imaging of neurotensin receptor expression in vivo
-
Maschauer, S.; Einsiedel, J.; Hocke, C.; Hübner, H.; Kuwert, T.; Gmeiner, P.; Prante, O. Synthesis of a Ga-68-labeled peptoid-peptide hybrid for imaging of neurotensin receptor expression in vivo ACS Med. Chem. Lett. 2010, 1, 224-228
-
(2010)
ACS Med. Chem. Lett.
, vol.1
, pp. 224-228
-
-
Maschauer, S.1
Einsiedel, J.2
Hocke, C.3
Hübner, H.4
Kuwert, T.5
Gmeiner, P.6
Prante, O.7
-
10
-
-
75749153010
-
18F-glycopeptides as effective imaging probes for positron emission tomography
-
18F- glycopeptides as effective imaging probes for positron emission tomography Angew. Chem., Int. Ed. 2010, 49, 976-979
-
(2010)
Angew. Chem., Int. Ed.
, vol.49
, pp. 976-979
-
-
Maschauer, S.1
Einsiedel, J.2
Haubner, R.3
Hocke, C.4
Ocker, M.5
Hübner, H.6
Kuwert, T.7
Gmeiner, P.8
Prante, O.9
-
11
-
-
79960615907
-
Novel DOTA-neurotensin analogues for In-111 scintigraphy and Ga-68 PET imaging of neurotensin receptor-positive tumors
-
Alshoukr, F.; Prignon, A.; Brans, L.; Jallane, A.; Mendes, S.; Talbot, J. N.; Tourwé, D.; Barbet, J.; Gruaz-Guyon, A. Novel DOTA-neurotensin analogues for In-111 scintigraphy and Ga-68 PET imaging of neurotensin receptor-positive tumors Bioconjugate Chem. 2011, 22, 1374-1385
-
(2011)
Bioconjugate Chem.
, vol.22
, pp. 1374-1385
-
-
Alshoukr, F.1
Prignon, A.2
Brans, L.3
Jallane, A.4
Mendes, S.5
Talbot, J.N.6
Tourwé, D.7
Barbet, J.8
Gruaz-Guyon, A.9
-
12
-
-
78649320159
-
Radiopharmaceutical chemistry for positron emission tomography
-
Li, Z. B.; Conti, P. S. Radiopharmaceutical chemistry for positron emission tomography Adv. Drug Delivery Rev. 2010, 62, 1031-1051
-
(2010)
Adv. Drug Delivery Rev.
, vol.62
, pp. 1031-1051
-
-
Li, Z.B.1
Conti, P.S.2
-
13
-
-
0020329198
-
Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Acetyl-neurotensin-(8-13) is the shortest analogue with full binding and pharmacological activities
-
DOI 10.1111/j.1432-1033.1982.tb05913.x
-
Granier, C.; Vanrietschoten, J.; Kitabgi, P.; Poustis, C.; Freychet, P. Synthesis and characterization of neurotensin analogs for structure activity relationship studies-Acetyl-neurotensin-(8-13) is the shortest analog with full binding and pharmacological activities Eur. J. Biochem. 1982, 124, 117-124 (Pubitemid 12094720)
-
(1982)
European Journal of Biochemistry
, vol.124
, Issue.1
, pp. 117-124
-
-
Granier, C.1
Van Rietschoten, J.2
Kitabgi, P.3
-
14
-
-
0035138361
-
In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors
-
DOI 10.1016/S0969-8051(00)00190-6, PII S0969805100001906
-
Garcia-Garayoa, E.; Allemann-Tannahill, L.; Blauenstein, P.; Willmann, M.; Carrel-Remy, N.; Tourwé, D.; Iterbeke, K.; Conrath, P.; Schubiger, P. A. In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors Nucl. Med. Biol. 2001, 28, 75-84 (Pubitemid 32155967)
-
(2001)
Nuclear Medicine and Biology
, vol.28
, Issue.1
, pp. 75-84
-
-
Garcia-Garayoa, E.1
Allemann-Tannahill, L.2
Blauenstein, P.3
Willmann, M.4
Carrel-Remy, N.5
Tourwe, D.6
Iterbeke, K.7
Conrath, P.8
Schubiger, P.A.9
-
15
-
-
14444284838
-
Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist
-
Gully, D.; Labeeuw, B.; Boigegrain, R.; OuryDonat, F.; Bachy, A.; Poncelet, M.; Steinberg, R.; SuaudChagny, M. F.; Santucci, V.; Vita, N.; Pecceu, F.; Labbe-Jullie, C.; Kitabgi, P.; Soubrie, P.; LeFur, G.; Maffrand, J. P. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist J. Pharmacol. Exp. Ther. 1997, 280, 802-812 (Pubitemid 27171343)
-
(1997)
Journal of Pharmacology and Experimental Therapeutics
, vol.280
, Issue.2
, pp. 802-812
-
-
Gully, D.1
Labeeuw, B.2
Boigegrain, R.3
Oury-Donat, F.4
Bachy, A.5
Poncelet, M.6
Steinberg, R.7
Suaud-Chagny, M.F.8
Santucci, V.9
Vita, N.10
Pecceu, F.11
Labbe-Jullie, C.12
Kitabgi, P.13
Soubrie, P.14
Le Fur, G.15
Maffrand, J.P.16
-
16
-
-
0001420460
-
Palladium-catalyzed amidation of aryl, heterocyclic, and vinylic halides
-
Schoenberg, A.; Heck, R. F. Palladium-catalyzed amidation of aryl, heterocyclic, and vinylic halides J. Org. Chem. 1974, 39, 3327-3331
-
(1974)
J. Org. Chem.
, vol.39
, pp. 3327-3331
-
-
Schoenberg, A.1
Heck, R.F.2
-
17
-
-
49149095251
-
6-mediated, palladium-catalyzed amino-carbonylation of aryl halides using allylamine: From exploration to scale-up
-
6-mediated, palladium-catalyzed amino-carbonylation of aryl halides using allylamine: from exploration to scale-up Tetrahedron Lett. 2008, 49, 5625-5628
-
(2008)
Tetrahedron Lett.
, vol.49
, pp. 5625-5628
-
-
Appukkuttan, P.1
Axelsson, L.2
Van Der Eycken, E.3
Larhed, M.4
-
18
-
-
84867578019
-
Metal-catalyzed amidation
-
Roy, S.; Roy, S.; Gribble, G. W. Metal-catalyzed amidation Tetrahedron 2012, 68, 9867-9923
-
(2012)
Tetrahedron
, vol.68
, pp. 9867-9923
-
-
Roy, S.1
Roy, S.2
Gribble, G.W.3
-
19
-
-
13244289863
-
Templated ceramic microstructures by using the breath-figure method
-
DOI 10.1002/chem.200400921
-
Englert, B. C.; Scholz, S.; Leech, P. J.; Srinivasarao, M.; Bunz, U. H. F. Templated ceramic microstructures by using the breath-figure method Chem.-Eur. J. 2005, 11, 995-1000 (Pubitemid 40188538)
-
(2005)
Chemistry - A European Journal
, vol.11
, Issue.3
, pp. 995-1000
-
-
Englert, B.C.1
Scholz, S.2
Leech, P.J.3
Srinivasarao, M.4
Bunz, U.H.F.5
-
20
-
-
84883133829
-
Efficient synthesis of heterocyclic neurotensin receptor ligands by microwave-assisted aminocarbonylation
-
Gmeiner, P.; Lang, C. Efficient synthesis of heterocyclic neurotensin receptor ligands by microwave-assisted aminocarbonylation Synthesis 2013, 45, 2474-2480
-
(2013)
Synthesis
, vol.45
, pp. 2474-2480
-
-
Gmeiner, P.1
Lang, C.2
-
21
-
-
63549126486
-
18F-labeling and glycosylation by click chemistry
-
18F-labeling and glycosylation by click chemistry Carbohydr. Res. 2009, 344, 753-761
-
(2009)
Carbohydr. Res.
, vol.344
, pp. 753-761
-
-
Maschauer, S.1
Prante, O.2
-
22
-
-
0028989925
-
3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand characterization of binding-properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor
-
3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand characterization of binding-properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor Mol. Pharmacol. 1995, 47, 1050-1056
-
(1995)
Mol. Pharmacol.
, vol.47
, pp. 1050-1056
-
-
Labbe-Jullie, C.1
Botto, J.M.2
Mas, M.V.3
Chabry, J.4
Mazella, J.5
Vincent, J.P.6
Gully, D.7
Maffrand, J.P.8
Kitabgi, P.9
-
23
-
-
0030846137
-
Nonpeptide antagonists of neuropeptide receptors: Tools for research and therapy
-
DOI 10.1016/S0165-6147(97)01109-7, PII S0165614797011097
-
Betancur, C.; Azzi, M.; Rostene, W. Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy Trends Pharmacol. Sci. 1997, 18, 372-386 (Pubitemid 27435060)
-
(1997)
Trends in Pharmacological Sciences
, vol.18
, Issue.10
, pp. 372-386
-
-
Betancur, C.1
Azzi, M.2
Rostene, W.3
-
24
-
-
0023247263
-
3-neurotensin
-
DOI 10.1016/0306-4522(87)90350-2
-
125I] Tyr3-neurotensin Neuroscience 1987, 22, 525-536 (Pubitemid 17140149)
-
(1987)
Neuroscience
, vol.22
, Issue.2
, pp. 525-536
-
-
Moyse, E.1
Rostene, W.2
Vial, M.3
Leonard, K.4
Mazella, J.5
Kitabgi, P.6
Vincent, J.-P.7
Beaudet, A.8
-
25
-
-
79955443599
-
Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics
-
Einsiedel, J.; Held, C.; Hervet, M.; Plomer, M.; Tschammer, N.; Hübner, H.; Gmeiner, P. Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics J. Med. Chem. 2011, 54, 2915-2923
-
(2011)
J. Med. Chem.
, vol.54
, pp. 2915-2923
-
-
Einsiedel, J.1
Held, C.2
Hervet, M.3
Plomer, M.4
Tschammer, N.5
Hübner, H.6
Gmeiner, P.7
-
26
-
-
0032484994
-
3H]SR 142948A, in the rat brain
-
DOI 10.1016/S0014-2999(97)01510-0, PII S0014299997015100
-
3H]SR 142948A, in the rat brain Eur. J. Pharmacol. 1998, 343, 67-77 (Pubitemid 28161053)
-
(1998)
European Journal of Pharmacology
, vol.343
, Issue.1
, pp. 67-77
-
-
Betancur, C.1
Canton, M.2
Burgos, A.3
Labeeuw, B.4
Gully, D.5
Rostene, W.6
Pelaprat, D.7
-
27
-
-
79955086916
-
64Cu-labeling and biological evaluation
-
64Cu-labeling and biological evaluation J. Inorg. Biochem. 2011, 105, 821-832
-
(2011)
J. Inorg. Biochem.
, vol.105
, pp. 821-832
-
-
Röhrich, A.1
Bergmann, R.2
Kretzschmann, A.3
Noll, S.4
Steinbach, J.5
Pietzsch, J.6
Stephan, H.7
|